Posted 6 months ago

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

ClinicalTrials.gov ID NCT06003231

Protocol number SGNDV-005

Sponsor Seagen Inc.

*Cohort Closed at this time*